Cite
HARVARD Citation
Menzies-Gow, A. et al. (2022). Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study. Lancet. 10 (1), pp. 47-58. [Online].